What Is Personalized Medicine and How Does It Work in Clinical Practice?

Updated

Personalized medicine is the practice of tailoring diagnosis and treatment to an individual patient's genetic, molecular, and environmental profile rather than treating all patients with the same condition identically. According to the International Society for Collaborating Scientists in Personalized Medicine (ISCSPM), this approach draws on post-genomic science to connect human health with everything from common, non-hazardous genetic expressions to rare genetic disorders. It applies when a clinician needs to interpret a patient's genetic profile and long-range health condition, and it depends on collaboration between physicians and scientists trained in human genetic analysis.

The Scientific Basis: Genetics and Molecular Biology

ISCSPM frames personalized medicine around the idea that undesirable genes can produce physiological symptoms directly or indirectly, by instigating or participating in various biochemical systems. Reading those effects requires more than surface-level clinical observation.

The core scientific inputs are:

  • Genetics — identifying genetic expressions that range from common and non-hazardous to rare disorders, such as those catalogued in the 2003 NORD's Guide to Rare Disorders.
  • Molecular and cell biology — analyzing disease at the molecular and cellular level to understand how a condition actually operates in a given patient.
  • Post-genomic science — using genomic data as the foundation for interpreting health conditions over the long range, not just at a single point in time.

ISCSPM states that scientists in this field must have thorough knowledge and experience in genetics in clinical practice. As a reference point, the site points to a virtual workshop in "Genetics in Clinical Practice" courtesy of Wayne Grody, M.D., Ph.D.

How Environmental and Physiological Parameters Enter the Plan

Personalized medicine is not purely genetic. ISCSPM describes designing environmental and physiological parameters suitable for the needs of the patient, and its scientific members prescribe a mode of treatment that includes the type of environment appropriate for the patient.

In practice, this means the individual treatment plan accounts for:

  1. The patient's genetic profile.
  2. The molecular and cellular analysis of the disease.
  3. Environmental factors that influence how the condition expresses itself.
  4. Physiological parameters specific to that patient.

Professionals specializing in nutrigenomics and environmental genetics are explicitly welcomed into this work, which signals that diet–gene and environment–gene interactions are treated as part of the clinical picture rather than separate concerns.

The Collaborative Model Behind Clinical Application

ISCSPM is composed of physicians and scientists involved in personalized medicine practice who are willing to undergo training in the area. Its stated mechanism is worldwide collaboration, which it expects to produce several concrete outputs:

  • Textbooks and journals on personalized medicine for professional use.
  • Coordination with agencies on the making and approval of orphan drugs.
  • Access to databases of all chromosomal genes.
  • Advanced protocols for molecular and cellular analysis of disease.
  • New treatments using molecular materials such as oligonucleotides.

Training is also offered by ISCSPM for aspiring members, and collaboration and consultation activities among members are instigated worldwide. M.D.s, Ph.D.s, professors, researchers, and other professionals in the field are invited to join.

What This Means for Patients

The scientific members of ISCSPM are described as physicians and scientists well trained in human genetic analyses who can read the genetic profiles of patients and populations and interpret their health conditions in the long range. For a patient, the practical promise is a specific, individual-appropriate diagnosis and treatment, plus guidance on present and future health conditions and the environment suited to them.

Where the Approach Is Applied

Application area What it involves
Nutrigenomics Factoring diet–gene interactions into individual care
Environmental genetics Matching treatment and environment to the patient
Rare disorders Addressing conditions such as those in the 2003 NORD's Guide to Rare Disorders
Orphan drug development Coordinating with agencies on making and approval
Molecular-based therapies Using molecular materials such as oligonucleotides

Key Takeaways

  • Personalized medicine tailors diagnosis and treatment to an individual's genetic, molecular, and environmental profile.
  • It rests on genetics and molecular/cell biology, applied by professionals with clinical genetics training.
  • Environmental and physiological parameters are part of the treatment plan, not an afterthought.
  • Progress depends on international collaboration, shared gene databases, standardized protocols, and ongoing training.
  • Patients seeking individualized diagnosis and long-range health interpretation are the intended beneficiaries of this model.